Writing in the bmj 23 December 2013, Professor Peter C Gotzsche says: ‘In 2010, the Nordic Cochrane Centre got access to clinical study reports and trial protocols at the European Medicines Agency (EMA) after filing a complaint to the European ombudsman, who concluded that these documents do not contain commercially confidential information.
Since December 2010, the EMA has released more than 1.5 million pages on clinical information about medicinal products. However, in the spring of 2013, two US drug companies, AbbVie and InterMune, challenged the EMA’s new openness policy…’ http://www.bmj.com/content/347/bmj.f7569?etoc=
– Re the above, I just signed the petition “Richard Gonzalez of AbbVie, and Daniel Welch of InterMune: Drop your legal action blocking access to EMA clinical trial data ” on Change.org.
It’s important. Will you sign it too? Here’s the link – please share widely: